home / stock / qtrx / qtrx news


QTRX News and Press, Quanterix Corporation From 05/07/24

Stock Information

Company Name: Quanterix Corporation
Stock Symbol: QTRX
Market: NASDAQ
Website: quanterix.com

Menu

QTRX QTRX Quote QTRX Short QTRX News QTRX Articles QTRX Message Board
Get QTRX Alerts

News, Short Squeeze, Breakout and More Instantly...

QTRX - Expected US Company Earnings on Tuesday, May 7th, 2024

Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...

QTRX - (QTRX) Investment Report

2024-05-03 20:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

QTRX - Quanterix To Report First Quarter 2024 Financial Results

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it will host a conference call on Wednesday, May 8, 2024 at 8:30 a.m. E.T., to discuss its first quarter 2024 financial results. Quanterix will issue...

QTRX - Long Term Trading Analysis for (QTRX)

2024-04-24 03:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

QTRX - Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure

Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, today announced a specific partnership path for laboratories interested in offering Tau based research and diagnostic testing services. Quanterix has secured over thirty ...

QTRX - Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer's Disease

Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, announced today that its Simoa ® phospho-Tau 217 (p-Tau 217) blood test has been granted Breakthrough Device designation by the U.S. Food and Drug Administration...

QTRX - Quanterix Corp. (NASDAQ: QTRX) Highlighted for Surprising Price Action

Quanterix Corporation (NASDAQ: QTRX) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 12.81% on the day to $27.03. Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassa...

QTRX - Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced financial results for the fourth quarter and twelve months ended December 31, 2023. “The fourth quarter marked the successful completion of our cor...

QTRX - Expected US Company Earnings on Thursday, February 29th, 2024

Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...

QTRX - Expected US Company Earnings on Tuesday, February 27th, 2024

First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...

Previous 10 Next 10